A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells
Jayoung Song, Jinha Yu, Lak Shin Jeong, Sang Kook Lee
Topics & Concepts
Synthetic lethalityCancer researchProstate cancerCancer cellApoptosisCancerDNA damageCell cycle checkpointCytarabineBiologyPharmacologyChemistryCell cycleDNA repairMedicineBiochemistryInternal medicineDNAMyeloid leukemiaMicrotubule and mitosis dynamicsCancer-related Molecular PathwaysDNA Repair Mechanisms